awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38657864-CED0585A-6F69-48DD-A265-A25298D16B7E
Q38657864-CED0585A-6F69-48DD-A265-A25298D16B7E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38657864-CED0585A-6F69-48DD-A265-A25298D16B7E
Optimizing the Bioavailability of Subcutaneously Administered Biotherapeutics Through Mechanochemical Drivers.
P2860
Q38657864-CED0585A-6F69-48DD-A265-A25298D16B7E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38657864-CED0585A-6F69-48DD-A265-A25298D16B7E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e5d5dcac5feb0259b77e9a49ba6970844590f7fc
P2860
PEGylation does not significantly change the initial intravenous or subcutaneous pharmacokinetics or lymphatic exposure of trastuzumab in rats but increases plasma clearance after subcutaneous administration.